BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15831668)

  • 1. Varicella zoster seroprevalence in children less than 5 years old.
    Ozkan S; Maral I; Ilhan F; Aycan S; Cirak MY; Beyazova U; Aygun R
    J Trop Pediatr; 2005 Jun; 51(3):141-4. PubMed ID: 15831668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
    Chang CK; Tan HF; Tseng HF; Lin CC
    Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea.
    Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
    Int J Infect Dis; 2008 May; 12(3):245-7. PubMed ID: 17950022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of varicella-zoster in Pakistan.
    Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey.
    Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD
    Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.
    Kowitdamrong E; Pancharoen C; Thammaborvorn R; Bhattarakosol P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S7-11. PubMed ID: 16622994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of varicella-zoster virus from vesicles in children with varicella.
    Ozaki T; Kajita Y; Namazue J; Yamanishi K
    J Med Virol; 1996 Apr; 48(4):326-8. PubMed ID: 8699164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
    J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.